Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 940-877-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin corrosion (OECD 431), EpiDermTM: non-corrosive
Skin irritation (OECD 439), EpiSkin: not irritating
Eye irritation (OECD 437), BCOP: corrosive
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16 Dec 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Human Skin Model Test)
- Version / remarks:
- adopted in 2004
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Landesinstitut für Arbeitsschutz und Produktsicherheit, München, Germany
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: EpiDerm, reconstructed three-dimensional human epidermis (EPI-200)
- Source strain:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- TEST SKIN MODEL
- Source: MatTek Corporation, Ashland MA, USA
TEST METHOD
EpiDermTMSCIT (EPI-200):
The model represents a reconstructed three-dimensional skin model based on normal human-derived epidermal keratinocytes which have been cultured to form a multilayered epidermis including basal, spinous and granular layers, and a multi-layered stratum corneum. Irritant materials are identified by their ability to penetrate the stratum corneum and to damage the underlaying cell layers which is determined through a decrease in cell viability as determined by MTT reduction assay.
ADAPTATION TO CELL CULTURE CONDITIONS
Upon receipt, tissues were transferred into 6-well plates containing 900 µL prewarmed assay medium per well and preincubated in a humidified incubator for at least 1 h (37 ± 1 °C, 5% CO2) before use.
INCUBATION CONDITIONS (INCUBATOR)
- Temperature (°C): 37 ± 1
- CO2 gas concentration (%): 5
- Humidity: maximum
REMOVAL OF TEST SUBSTANCE
- Washing: The test item was washed from the skin surface with phosphate buffered saline.
- Time after start of exposure: 3 and 60 min
CELL VIABILITY MEASUREMENTS
For determining alterations in cell viability, MTT reduction assays were performed. Therefore, tissues were incubated in 300 µL prewarmed MTT solution for 3 h at 37 ± 1 °C and 5% CO2. After aspiration of the MTT solution, tissues were washed 3 times in phosphate buffered saline followed by tissue drying. Extraction of the formazan product was carried out in 2 mL isopropanol. The optical density was measured at 550 nm wave length in a plate spectrophotometer. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount applied: 25 mg
- Concentration: 100% (moistened with 25 µL water)
POSITIVE CONTROL SUBSTANCE:
- Positive control substance: Potassium hydroxide (8 N, CAS 1310-58-3, Lot 10357004) - Duration of treatment / exposure:
- 3 and 60 min
- Number of replicates:
- The test was performed in duplicates for each test or control group and treatment period (3 and 60 min).
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 3 min of exposure
- Value:
- 93
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 60 min of exposure
- Value:
- 88
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- After treatment with the test item the viability was 93% and 88% after treatment for 3 and 60 min, respectively. Therefore the test item is considered to be not corrosive.
- Interpretation of results:
- other: non-corrosive (Skin Irrit. 2 or not classified according to Regulation (EC) No 1272/2008)
- Conclusions:
- There is regulatory acceptance in the EU that a substance can be considered corrosive based on a positive result in the human epidermis model test. Negative in vitro corrosivity responses are not conclusive with respect to non-classification or classification as irritant and shall therefore be subject to further evaluation.
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12 Dec 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- adopted in 2001
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Landesinstitut für Arbeitsschutz und Produktsicherheit, München, Germany
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: EpiSkin, reconstructed three-dimensional human epidermis (EpiskinSM)
- Source strain:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- TEST SKIN MODEL
- Source: SkinEthic laboratories, Lyon, France
TEST METHOD
EpiSkin small model (Batch No. 12-EKIN-013):
The model represents a reconstructed three-dimensional skin model based on normal adult human-derived epidermal keratinocytes which have been cultured to form a multilayered epidermis including basal, spinous and granular layers, and a functional stratum corneum. Irritant materials are identified by their ability to penetrate the stratum corneum and to damage the underlaying cell layers which is determined through a decrease in cell viability as determined by MTT reduction assay.
ADAPTATION TO CELL CULTURE CONDITIONS
Upon receipt, tissues were transferred into 12-well plates containing 2 mL prewarmed assay medium per well and preincubated in a humidified incubator for at least 24 h (37 ± 1 °C, 5% CO2) before use.
INCUBATION CONDITIONS (INCUBATOR)
- Temperature (°C): 37 ± 1
- CO2 gas concentration (%): 5
- Humidity: maximum
TEST SITE
- Area of exposure: 0.38 cm²
REMOVAL OF TEST SUBSTANCE
- Washing: The test item was washed from the skin surface with phosphate buffered saline.
- Time after start of exposure: 15 min
CELL VIABILITY MEASUREMENTS
For determining alterations in cell viability, MTT reduction assays were performed. Therefore, tissues were incubated in 2 mL prewarmed MTT solution for 3 h at 37 ± 1 °C and 5% CO2. After the 3 h MTT incubation period the tissues were placed on blotting paper to dry the tissues. Afterwards a total biopsy of the epidermis by using the special biopsy punch was performed and the epidermis was separated from the collagen matrix with the aid of forceps. Both parts were transferred into suitable tubes and 500 µL of acidic isopropanol were added. Extraction was carried out protected from light over the weekend at 2-8°C. At the end of the formazan extraction period the tubes were mixed by vortexing until solution colour became homogeneous. If any visible cell/tissue fragments were in suspension, the tubes were centrifuged at 500 rpm to eliminate the fragments and avoid further possible interference with the absorbance readings. Per each tissue 2x200 µL aliquots of the extract were transferred into a 96-well plate and OD was measured at 550m nmwithout reference wavelength in a plate spectrophotometer. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount applied: 10 mg
- Concentration: 100% (moistened with 10 µL water)
POSITIVE CONTROL SUBSTANCE:
- Positive control substance: Sodium Dodecyl Sulfate (5%, SDS, CAS 151-21-3, Lot 9S009119) - Duration of treatment / exposure:
- 15 min
- Duration of post-treatment incubation (if applicable):
- 42 h
- Number of replicates:
- The test was performed in triplicates for each test or control group.
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 15 min of exposure
- Value:
- 112
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- After treatment with the test item the viability was 112 after treatment for 15 min and a 42-h post-incubation period. Therefore the test item is considered to be not irritant.
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008
- Conclusions:
- CLP: not classified
Referenceopen allclose all
Table 1: MTT assay after 3 min exposure
|
Negative control |
Positive control |
Test item |
|||
Tissue sample |
1 |
2 |
1 |
2 |
1 |
2 |
OD550 |
2.088 2.085 2.082 |
1.947 1.985 1.978 |
0.309 0.315 0.312 |
0.269 0.271 0.269 |
2.001 1.907 1.878 |
1.803 1.859 1.818 |
OD550(mean) |
2.085 |
1.970 |
0.312 |
0.270 |
1.929 |
1.827 |
SD |
0.003 |
0.020 |
0.003 |
0.001 |
0.064 |
0.029 |
OD550(mean values of replicates) |
2.028 |
0.291 |
1.878 |
|||
Viability (%) |
100 |
14 |
93 |
|||
Mean inter tissue viability difference (%) |
5.7 |
14.5 |
5.4 |
Table 2: MTT assays after 60 min exposure
|
Negative control |
Positive control |
Test item |
|||
Tissue sample |
1 |
2 |
1 |
2 |
1 |
2 |
OD550 |
2.032 1.954 1.976 |
2.014 1.992 1.974 |
0.114 0.117 0.115 |
0.119 0.129 0.121 |
1.857 1.754 1.762 |
1.742 1.717 1.736 |
OD550(mean) |
1.987 |
1.993 |
0.115 |
0.123 |
1.791 |
1.732 |
SD |
0.040 |
0.020 |
0.002 |
0.005 |
0.057 |
0.013 |
OD550(mean values of replicates) |
1.990 |
0.119 |
1.761 |
|||
Viability (%) |
100 |
6 |
88 |
|||
Mean inter tissue viability difference (%) |
0.3 |
6.4 |
3.4 |
Table 3: Historical data
|
mean |
SD |
n |
OD550of Negative Controls (3 min) |
1.731 |
0.176 |
25 |
OD550of Negative Controls (60 min) |
1.748 |
0.192 |
25 |
Relative tissue viability (%) of positive controls (3 min) |
19.0 |
5.958 |
24 |
Max. inter tissue viability difference (%) |
13.9 |
6.627 |
144 |
Table 1: MTT assay after 15 min exposure
|
Negative control |
Positive control |
Test item |
||||||
Tissue sample |
1 |
2 |
3 |
1 |
2 |
3 |
1 |
2 |
3 |
OD550 |
0.904 0.909 |
0.959 0.946 |
0.937 0.928 |
0.084 0.083 |
0.087 0.097 |
0.079 0.082 |
1.071 1.092 |
0.950 0.975 |
1.060 1.087 |
OD550(mean) |
0.863 |
0.909 |
0.890 |
0.041 |
0.049 |
0.038 |
1.039 |
0.919 |
1.031 |
OD550(mean values of replicates) |
0.887 |
0.042 |
0.996 |
||||||
SD |
0.021 |
0.006 |
0.061 |
||||||
Viability (%) |
100 |
5 |
112 |
||||||
Mean inter tissue viability difference (%) |
2.6 |
14.0 |
6.7 |
Table 2: Quality criteria
|
value |
cut off |
pass/fail |
OD550blank |
0.043 |
<0.1 |
pass |
Absolute OD550of Negative Controls |
0.930 |
0.6≤NC≤1.5 |
pass |
Relative tissue viability (%) of positive controls |
5.0 |
≤40 |
pass |
Max. inter tissue viability difference (%) |
0.7-7.5 |
<18 |
pass |
Table 3: Historical data
|
mean |
SD |
n |
OD550of Negative Controls |
0.44 |
0.002 |
20 |
Absolute OD550of Negative Controls |
0.863 |
0.143 |
20 |
Relative tissue viability (%) of positive controls |
10.2 |
6.030 |
20 |
Max. inter tissue viability difference (%) |
5.3 |
3.742 |
62 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13 Mar 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants)
- Version / remarks:
- adopted in 2009
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Landesinstitut für Arbeitsschutz und Produktsicherheit, München, Germany
- Species:
- cattle
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- TEST METHOD
The bovine corneal opacity and permeability (BCOP) test is an in-vitro test method used for identifying i) chemicals inducing serious eye damage and ii) chemicals not requiring classification for eye irritation or serious eye damage. The potential of a test substance to cause ocular corrosivity or severe irritancy is measured by its ability to induce opacity and increased permeability in an isolated bovine cornea. The opacity and permeability assessments of the cornea are combined to derive an in-vitro irritancy score (IVIS), which is used to classify the irritancy level of the test substance.
IDENTIFICATION OF THE SOURCE OF THE EYES, STORAGE AND TRANSPORT CONDITIONS
- Source: Attenberger Fleisch GmbH&Co. KG, München, Germany
- Donor animals: no details given
- Date and time of eye collection: directly before the start of the experiment
- Time interval prior to initiating testing: no details given
- Transport medium and temperature conditions: Hanks´ Balanced Salt Solution (HBSS) on ice with penicillin/streptomycin
PREPARATION OF THE EYES (BEFORE EXPOSURE)
- Eyes free of defects (scratches, neovascularisation): yes
- Dissection of the eyes and treatment: Corneas were dissected with a 2 to 3 mm rim of sclera. Isolated corneas were mounted in cornea holders.
- Type of cornea holder used: MC2 (Clermont, France)
- Description of the cornea holder: The cornea holders consist of an anterior and a posterior compartment, which interface with the epithelial and endothelial sides of the cornea.
- Test medium and temperature conditions used in the cornea holder: RPMI with and without phenol red, supplemented with 1% [v/v] fetal calf serum and 2 mM L-glutamine; prior to use: pre-warmed to 32 ± 1 °C
- Equilibration time: 1 h at 32 ± 1 °C
- Quality check of the equilibrated corneas: initial opacity of 2 (corneas with an initial opacity above 7 in the opacitometer or with any macroscopic defects were not used)
DETERMINATION OF THE INITIAL OPACITY
- Method: Corneal opacity was determined by the amount of light transmission through the cornea via an opacitometer and was read against an air-filled chamber.
- Specification of the device: MC2, Clermont, France - Vehicle:
- physiological saline
- Controls:
- other: number of eyes for the negative control: 3; number of eyes for the positive control: 3
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 750 µL
- Concentration: 20%
VEHICLE
- Substance: physiol. saline
- Concentration: 0.9% NaCl solution in deionised water
- Amount applied: 750 µL
POSITIVE SUBSTANCE
- Substance: imidazole in physiol. saline
- Concentration: 20% imidazole in 0.9% NaCl solution in deionised water
- Amount applied: 750 µL - Duration of treatment / exposure:
- 4 h at 32 ± 1 °C
- Number of animals or in vitro replicates:
- Number of eyes for the test item: 3
- Details on study design:
- TEST CONDITIONS
- Short description of the method used: closed-chamber method
POST-EXPOSURE TREATMENT
- Removal of the test substance: The test substance was removed from the anterior chamber and the epithelium washed at least three times.
- Medium for washing the corneas: MEM containing phenol red
- Medium for final rinsing: RPMI without phenol red
DETERMINATION OF THE FINAL OPACITY
- Method: Corneal opacity was determined by the amount of light transmission through the cornea via an opacitometer.
- Time of determination: Directly after refilling complete RPMI without phenol red in the anterior chamber the final opacity was measured.
- Specification of the device: MC2, Clermont, France
DETERMINATION OF THE CORNEAL PERMEABILITY:
- Method: Sodium fluorescein solution was added to the anterior chamber of the cornea holder while the posterior chamber was filled with fresh medium. The amount of sodium fluorescein that crosses into the posterior chamber was quantitatively measured via UV/VIS spectrophotometry at 490 nm recorded as optical density (OD490).
- Amount and concentration of the dye: 1 mL sodium fluorescein solution (5 mg/mL)
- Incubation time: 90 min at 32 ± 1 °C
- Treatment for measuring: OD490 of a 1 mL aliquot was determined.
- Dilution of the medium: undiluted
- Specification of the spectrophotometer: Jenway, UK - Irritation parameter:
- in vitro irritation score
- Remarks:
- mean out of all 3 eyes
- Run / experiment:
- 4 h exposure
- Value:
- 235.99
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- An IVIS of 235.99 was observed for the test substance indicating that the test susbstance has corrosive or severe irritant properties.
- Interpretation of results:
- other: CLP/EU GHS Category 1 according to Regulation (EC) No. 1272/2008
- Conclusions:
- CLP: Cat. 1, H318
Reference
Table 1: Opacity values
Parameter |
Initial opacity |
Final opacity |
Opacity change |
Mean opacity change of NC |
Corrected opacity change |
Mean opacity value |
Negative control |
2 |
1 |
-1 |
-0.67 |
- |
- |
2 |
1 |
-1 |
|
|||
2 |
2 |
0 |
|
|||
Test substance |
1 |
216 |
215 |
- |
215.67 |
236 |
2 |
266 |
264 |
264.67 |
|||
2 |
229 |
227 |
227.67 |
|||
Positive control |
3 |
162 |
159 |
- |
159.67 |
158 |
3 |
194 |
191 |
191.67 |
|||
3 |
125 |
122 |
122.67 |
Table 2: Permeability values (optical density (OD) at 490 nm)
Parameter |
OD490 |
Mean OD490 value |
Corrected OD490 values |
Mean Corrected OD490 values |
Negative control |
0.010 |
0.010 |
- |
- |
0.007 |
||||
0.012 |
||||
Test substance |
0.003 |
0.009 |
-0.007 |
-0.001 |
0.012 |
0.002 |
|||
0.012 |
0.002 |
|||
Positive control |
1.702 |
1.651 |
1.692 |
1.641 |
1.511 |
1.501 |
|||
1.740 |
1.730 |
Table 3: In-Vitro Irritancy Score (IVIS) values
|
Mean IVIS |
|
Test substance |
235.99 |
|
Positive control |
182.62 |
|
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation
Reaction mass of 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid and 2-(4,5-dimethyl-1H-pyrazol-1-yl)succinic acid was tested for its skin corrosion potential in the EpiDermTMSkin Model, which is a three-dimensional in-vitro model of the human epidermis and is used to distinguish between corrosive and non-corrosive chemicals (Lehmeier, 2012a). The skin corrosion test was performed according to OECD guideline 431 and in compliance with GLP. 25 mg Reaction mass of 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid and 2-(4,5-dimethyl-1H-pyrazol-1-yl)succinic acid (moistened with water) was applied to the intact reconstructed human epidermis for 3 and 60 min, respectively. Duplicate cultures were used for each group and treatment period. Concurrent control tissues treated with A. dest. served as negative controls, positive controls were exposed to 8N KOH. After the treatment the test item was washed from the skin surface with phosphate-buffered saline. For determining alterations in cell viability, MTT reduction assays were performed. The relative cell viability for the test item was 93% and 88% after 3 and 60 min, respectively. Therefore, the test substance was considered to be non-corrosive as the evaluation criteria for non-corrosivity (≥50% viability after 3 min and ≥15% viability after 60 min) were met. After treatment with the positive control substance KOH the viability was reduced to 14% and 6% after 3 and 60 min, respectively. The positive control met the criteria for corrosivity (<50% viability after 3 min). In conclusion, the test substance was not corrosive under the conditions of the study.
In concordance with the Integrated Testing Strategy (ITS) described in the ECHA guidance document (ECHA, 2013) an in-vitro skin irritation test was performed with Reaction mass of 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid and 2-(4,5-dimethyl-1H-pyrazol-1-yl)succinic acid according to OECD guideline 439 and in compliance with GLP in a reconstructed three-dimensional human epidermis model (EpiskinSM) (Lehmeier, 2012b). 10 mg Reaction mass of 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid and 2-(4,5-dimethyl-1H-pyrazol-1-yl)succinic acid (moistened with water) was applied to the intact reconstructed human epidermis for 15 min. After treatment the skin was washed with phosphate-buffered saline (PBS) and was further incubated for 42 h. Triplicate cultures were used for each test or control group. Concurrent control tissues treated with PBS served as negative controls, positive controls were exposed to 5% SDS. For determining alterations in cell viability, MTT reduction assays were performed.
The relative cell viability was 112% and 5% for the test item and the positive control, respectively. The positive control met the criteria as an irritant (≤50% viability after 15 min treatment). The test item met the criteria as not irritant (>50% viability after 15 min treatment). The test acceptance criteria were met, therefore the test substance is considered to be not irritant under the conditions of the study.
In conclusion, according to the ITS for irritation/corrosion (ECHA, 2013) Reaction mass of 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid and 2-(4,5-dimethyl-1H-pyrazol-1-yl)succinic acid is considered to be not irritant to skin as validated in-vitro skin corrosion and skin irritation tests were negative and no other information is available indicating that the substance is irritating to skin.
Eye irritation
Reaction mass of 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid and 2-(4,5-dimethyl-1H-pyrazol-1-yl)succinic acid was tested for its eye irritation potential in a study according to OECD guideline 437 (BCOP) in bovine eyes (Lütkenhaus, 2012). Fresh eyes were collected at the day of the experiment and were prepared before use. Corneas were dissected with a 2-3 mm rim of sclera and were mounted in cornea holders (3 corneas per group). 750 µl of a test substance solution (20% in physiological saline) was applied to the cornea and incubated for 4 h at 32°C (closed-chamber method). 750 µL of a 20% imidazole solution was used as a positive control. After treatment the corneas were washed with MEM containing phenol red and the corneal opacity was determined by the amount of light transmission through the cornea via an opacitometer. For assessment of the corneal permeability sodium fluorescein (5 mg/mL) solution was added to the anterior chamber of the cornea holder while the posterior chamber was filled with fresh medium. The amount of sodium fluorescein that crosses into the posterior chamber (within 90 min at 32°C) was quantitatively measured via UV/VIS spectrophotometry at 490 nm recorded as optical density (OD490). The mean opacity value, mean corrected OD490 value and the in-vitro irritancy score (IVIS) for the test substance were 236, -0.001, and 235.99, respectively. For the positive control the mean opacity value, mean corrected OD490 value and the in-vitro irritancy score were 158, 1.641, and 182.62. IVIS ≥55 indicate corrosive/severe irritant properties according to CLP regulation. In conclusion, the test substance was corrosive/severely irritant under the conditions of the study, and has to be classified as Cat 1 (H318) according to CLP regulation.
Justification for classification or non-classification
The available data on skin irritation of Reaction mass of 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid and 2-(4,5-dimethyl-1H-pyrazol-1-yl)succinic acid do not meet the criteria for classification according to Regulation (EC) 1272/2008, and are therefore conclusive but not sufficient for classification.
The available data on eye irritation of the Reaction mass of 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid and 2-(4,5-dimethyl-1H-pyrazol-1-yl)succinic acid meet the criteria for classification as 'Causes serious eye damage: Cat 1 (H318) according to Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.